A role for cathepsin B has previously been reported in several triple-negative breast cancer cell lines that are not IBC (e.g., BT20, BT549, MCF-10AneoT, and MDA-MB-231) [31,46-48], and inhibition of active cathepsin B in these cells reduced their invasion in vitro. This evidence concerns the gene CTSB and triple-negative breast carcinoma.